Chemist Warehouse owner withdraws from $14b Boots sale talks (opens original article in a new tab)
Sigma Healthcare ends talks to buy UK's Boots for $14b, focusing on Australian growth instead, with shares rising 8% following the announcement.
- Sigma Healthcare withdraws from $14b Boots sale talks
- Sigma focuses on Australian market for growth
- Sigma shares rose 8% after announcement
Conversation
No comments yet
Threaded discussion is coming next — this is where the community conversation about this story will live.